H-L-Phe-OBzl*HCl is a protected phenylalanine derivative in which the carboxyl group is esterified as a benzyl ester (OBzl) and the amino group is presented as a free amino terminus (H-) with an overall hydrochloride salt form. The molecule features a benzyl-protected carboxyl ester alongside the α-amino functionality and an anilide-like phenyl side chain, with the stereochemistry indicated as L at the α-carbon. As an amino acid ester hydrochloride, it is used as a peptide-synthesis building block or intermediate in stepwise assembly routes where the benzyl ester can be removed under appropriate deprotection conditions to regenerate the free carboxyl group for subsequent coupling or derivatization.
CAT No: CP25653
CAS No:2462-32-0
Synonyms/Alias:2462-32-0;L-Phenylalaninebenzylesterhydrochloride;H-Phe-OBzl.HCl;(S)-Benzyl2-amino-3-phenylpropanoatehydrochloride;H-PHE-OBZLHCL;L-PHENYLALANINEBENZYLESTERHCL;SBB058269;phenylmethyl(2S)-2-amino-3-phenylpropanoate,chloride;PubChem19007;BENZYL(2S)-2-AMINO-3-PHENYLPROPANOATEHYDROCHLORIDE;78060_ALDRICH;SCHEMBL353729;78060_FLUKA;CTK3J1718;CEXFHIYDTRNBJD-RSAXXLAASA-N;MolPort-003-939-035;ANW-25495;MFCD00043249;AKOS015889857;AKOS015922770;RTR-011345;AK-40673;SC-66038;AB1008609;DB-029979
Chemical Name:L-Phenylalanine benzyl ester hydrochloride
H-L-Phe-OBzl*HCl is a protected dipeptide derivative consisting of L-phenylalanine linked in an amino-acid backbone arrangement and capped as a benzyl ester, with the material present as a hydrochloride salt. The structure contains a stereodefined L-phenylalanine residue, a benzyloxycarbonyl-type ester functionality (OBzl) that can be manipulated under hydrogenolysis or acid/base conditions depending on the protecting-group scheme, and an amino functionality in salt form that supports controlled peptide coupling chemistry. The benzyl ester masking of the C-terminal carboxyl group enables compatibility with peptide synthesis workflows where selective deprotection and subsequent acylation are required. Salt formation with HCl modulates handling and solubility while maintaining the chiral integrity of the phenylalanine stereocenter for downstream synthesis of peptide building blocks and analogs.
1. Peptide Synthesis
H-L-Phe-OBzl*HCl is used in peptide synthesis as a C-terminal benzyl-ester protected phenylalanine-containing building block that supports stepwise coupling strategies toward longer peptide chains. The benzyl ester protects the carboxyl equivalent, allowing amide bond formation at the adjacent amino functionality while deferring C-terminal unmasking until the desired stage of assembly. Salt-form amino activation and subsequent coupling can be integrated into protected amino acid chemistry to maintain stereochemical fidelity of the L-phenylalanine residue. The resulting intermediates can be carried forward to generate peptide fragments, sequence-defined oligomers, and protected peptide targets for further derivatization.
2. Protected Amino Acid Chemistry
H-L-Phe-OBzl*HCl is suitable for protected amino acid synthesis and protecting-group strategy development, where the OBzl ester serves as a removable C-terminal protecting group in orthogonal deprotection planning. The phenylalanine side chain provides an aromatic handle that can tolerate common coupling conditions and supports later functionalization or analytical differentiation. Hydrochloride salt formation helps control the protonation state of the amino functionality during handling and can be aligned with standard peptide coupling reagent compatibility. Downstream use frequently includes conversion to free carboxylic acid forms, re-esterification, or incorporation into peptide analog libraries where selective deprotection defines the synthetic sequence.
3. Chemical Biology Research
H-L-Phe-OBzl*HCl can be applied in chemical biology workflows that require phenylalanine-containing peptide fragments for studying molecular recognition, binding interfaces, or enzyme processing of peptide substrates. The protected ester and controlled amino functionality enable preparation of defined peptide termini that can be converted into carboxyl- or amide-bearing derivatives for conjugation or assay-ready constructs. The aromatic phenyl side chain contributes to hydrophobic and π-interaction patterns that are often relevant in peptide-protein and peptide-receptor binding studies. The compound's chiral specificity supports stereochemically defined fragment generation for structure-activity relationship studies and mechanistic investigations using peptide-based reagents.
4. Bioconjugation Chemistry
H-L-Phe-OBzl*HCl is utilized in bioconjugation chemistry as a protected amino acid/peptide intermediate that can be transformed into conjugatable peptide motifs after deprotection and functional group adjustment. The benzyl ester can be removed to reveal a carboxyl group suitable for activation and subsequent coupling to amines, hydrazides, or linker systems under peptide-compatible conditions. The L-phenylalanine residue provides a stable aromatic moiety that can serve as a structural anchor in linker-bearing conjugates and can aid in LC-MS traceability of labeled constructs. The hydrochloride salt form supports reproducible intermediate handling during the preparation of peptide linkers for biomolecule labeling and downstream analytical characterization.
5. Pharmaceutical Manufacturing
H-L-Phe-OBzl*HCl is relevant to pharmaceutical manufacturing and process chemistry where protected peptide intermediates are manufactured under controlled protecting-group schemes for consistent downstream coupling. The benzyl ester protection of the C-terminus supports purification-compatible intermediate isolation and allows sequential deprotection to generate defined reactive termini for subsequent acylation steps. The stereodefined L-phenylalanine component helps maintain chiral integrity through the manufacturing route, reducing the risk of racemization during protected-stage transformations. The material can function as a practical intermediate for producing peptide fragments used in larger synthetic sequences, including peptidomimetic precursors and peptide-derived process intermediates.
1. Implications of ligand-receptor binding kinetics on GLP-1R signalling
2. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
3. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
4. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.